首页> Urologic oncology> Specificities of small cell neuroendocrine prostate cancer: Adverse prognostic value of TTF1 expression.

Specificities of small cell neuroendocrine prostate cancer: Adverse prognostic value of TTF1 expression.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mathilde,Cancel

第一单位： Inserm UMR1069 "Nutrition, Croissance et Cancer" Université de Tours, CHRU Bretonneau, Tours, France; Department of Oncology, Tours, France.

作者： Mathilde,Cancel ^[1] ; Claire,Castellier ^[2] ; Celine,Debiais-Delpech ^[3] ; Thomas,Charles ^[4] ; François,Rozet ^[5] ; Nathalie,Rioux-Leclercq ^[6] ; Romain,Mathieu ^[7] ; Françoise,Beltjens ^[8] ; Luc,Cormier ^[9] ; Franck,Bruyère ^[10] ; Gaëlle,Fromont ^[11]

作者单位： Inserm UMR1069 "Nutrition, Croissance et Cancer" Université de Tours, CHRU Bretonneau, Tours, France; Department of Oncology, Tours, France. ^[1] Department of Pathology, Tours, France. ^[2] CHU Poitiers, Department of Pathology, Poitiers, France. ^[3] CHU Poitiers, Department of Urology, Poitiers, France. ^[4] Institut Mutualiste Montsouris, Department of Urology, Paris, France. ^[5] CHU Rennes, Department of Pathology, Rennes, France. ^[6] CHU Rennes, Department of Urology, Rennes, France. ^[7] Centre Georges Francois Leclerc, Department of Pathology, Dijon, France. ^[8] Centre Georges Francois Leclerc, CHU Dijon, Department of Urology, Dijon, France. ^[9] Department of Urology, Tours, France. ^[10] Inserm UMR1069 "Nutrition, Croissance et Cancer" Université de Tours, CHRU Bretonneau, Tours, France; Department of Pathology, Tours, France. Electronic address: gaelle.fromont-hankard@univ-tours.fr. ^[11]

关键词 Neuroendocrine carcinoma Prognosis Prostate cancer